Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guoxiang Chu

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Novartis Foundation Symposium|October 6, 2006
Phospholamban as a therapeutic modality in heart failureGuoxiang Chu, Evangelia G Kranias
Basic Research in Cardiology|December 14, 2002
Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse modelsGuoxiang Chu, Evangelia G Kranias
Journal of Cardiac Failure|January 30, 2003
From mouse to man: understanding heart failure through genetically altered mouse modelsGuoxiang Chu, Kobra Haghighi, Evangelia G Kranias
Trends in Cardiovascular Medicine|August 16, 2005
Hsp20 and its cardioprotectionGuo-Chang Fan, Guoxiang Chu, Evangelia G Kranias
Plos One|March 11, 2015
Relationship of exercise capacity and left ventricular dimensions in patients with a normal ejection fraction. An exploratory studyMarkus Meyer, Rachel K McEntee, Iwan Nyotowidjojo, et al.
Biochemical and Biophysical Research Communications|December 8, 2006
Junctin is a prominent regulator of contractility in cardiomyocytesGuo-Chang Fan, Qunying Yuan, Wen Zhao, et al.
Circulation Research|April 24, 2004
Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosisGuo-Chang Fan, Guoxiang Chu, Bryan Mitton, et al.
Journal of Molecular and Cellular Cardiology|July 28, 2004
Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractilityWen Zhao, Yoshiki Uehara, Guoxiang Chu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2004
Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodelingQiujing Song, Karen B Young, Guoxiang Chu, et al.
Cardiovascular Research|December 31, 2002
Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac stateWen Zhao, Konrad F Frank, Guoxiang Chu, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Novartis Foundation Symposium|October 6, 2006
Phospholamban as a therapeutic modality in heart failureGuoxiang Chu, Evangelia G Kranias
Basic Research in Cardiology|December 14, 2002
Functional interplay between dual site phospholambam phosphorylation: insights from genetically altered mouse modelsGuoxiang Chu, Evangelia G Kranias
Journal of Cardiac Failure|January 30, 2003
From mouse to man: understanding heart failure through genetically altered mouse modelsGuoxiang Chu, Kobra Haghighi, Evangelia G Kranias
Trends in Cardiovascular Medicine|August 16, 2005
Hsp20 and its cardioprotectionGuo-Chang Fan, Guoxiang Chu, Evangelia G Kranias
Plos One|March 11, 2015
Relationship of exercise capacity and left ventricular dimensions in patients with a normal ejection fraction. An exploratory studyMarkus Meyer, Rachel K McEntee, Iwan Nyotowidjojo, et al.
Biochemical and Biophysical Research Communications|December 8, 2006
Junctin is a prominent regulator of contractility in cardiomyocytesGuo-Chang Fan, Qunying Yuan, Wen Zhao, et al.
Circulation Research|April 24, 2004
Small heat-shock protein Hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosisGuo-Chang Fan, Guoxiang Chu, Bryan Mitton, et al.
Journal of Molecular and Cellular Cardiology|July 28, 2004
Threonine-17 phosphorylation of phospholamban: a key determinant of frequency-dependent increase of cardiac contractilityWen Zhao, Yoshiki Uehara, Guoxiang Chu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 3, 2004
Overexpression of phospholamban in slow-twitch skeletal muscle is associated with depressed contractile function and muscle remodelingQiujing Song, Karen B Young, Guoxiang Chu, et al.
Cardiovascular Research|December 31, 2002
Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac stateWen Zhao, Konrad F Frank, Guoxiang Chu, et al.
Pageof 2